Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

Benjamin A Fisher, Darren Plant, Monica Brode, Ronald F van Vollenhoven, Linda Mathsson, Deborah Symmons, Karin Lundberg, Johan Rönnelid, Patrick J Venables

Research output: Contribution to journalArticlepeer-review

42 Citations (Scopus)

Abstract

The anticyclic citrullinated peptide 2 (anti-CCP2) assay is a generic test for antibodies to citrullinated proteins, among which there is a subset of about 50% with antibodies to citrullinated enolase peptide 1 (CEP-1). The anti-CEP-1 positive subset is strongly associated with the HLA-DRB1 shared epitope and its interaction with smoking.
Original languageEnglish
Pages (from-to)1095-8
Number of pages4
JournalAnnals of the Rheumatic Diseases
Volume70
Issue number6
DOIs
Publication statusPublished - 2011

Fingerprint

Dive into the research topics of 'Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis'. Together they form a unique fingerprint.

Cite this